BRENDA BUSH: Open Payments
NPI 1316192610 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $32 |
| Corium, LLC | 1 | $25 |
| GENZYME CORPORATION | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
Products named: COBENFY, CAPLYTA, REXULTI, AUSTEDO XR, VRAYLAR, ABILIFY MAINTENA, Azstarys, ALTUVIIIO.
Industry payments across MO — which companies pay providers there.
